Category: Investor Relations

Explanation on Confidentiality Measures and Confidentiality System Adopted for This Transaction

20250819081544687 Download

August 19, 2025
Explanation on the Basis and Fairness of the Pricing for This Transaction

20250819081515409 Download

August 19, 2025
Explanation on This Transaction’s Compliance with Article 18 and Article 21 of the Measures for Continuous Supervision of GEM Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Rules for the Review of Major Asset Restructurings of Listed Companies

20250819081359445 Download

August 19, 2025
Explanation on This Transaction’s Compliance with Article 4 of the Guidelines for the Supervision of Listed Companies No. 9—Supervisory Requirements for the Planning and Implementation of Major Asset Restructurings by Listed Companies

20250819081330326 Download

August 19, 2025
Explanation on the compliance of this transaction with Article 11 of the Administrative Measures for the Registration of Securities Issuance by Listed Companies

20250819081259311 Download

August 19, 2025
Explanation on the compliance of this transaction with Articles 11, 43, and 44 of the Administrative Measures for the Major Asset Restructuring of Listed Companies

20250819081228213 Download

August 19, 2025
Explanation on the related party transaction nature of this transaction

20250819081154305 Download

August 19, 2025
Explanation on the completeness and compliance of the statutory procedures performed for this transaction and the validity of the submitted legal documents

20250819081128251 Download

August 19, 2025
Explanation on the purchase and sale of assets within 12 months prior to this transaction

20250819081058105 Download

August 19, 2025
Explanation on whether this transaction will dilute the immediate returns of the listed company and the corresponding measures

20250819081026787 Download

August 19, 2025